|
[1]
|
Hamid, S., Umar, M., Alam, A., Siddiqui, A., Qureshi, H., Butt, J., et al. (2004) PSG consensus statement on the management of hepatitis C virus nfection-2003. Journal of the Pakistan Medical Association, 54, 146-150.
|
|
[2]
|
Alter, M.J. (1997) Epidemiology of hepatitis C. Hepatology, 26, 62S. doi:10.1002/hep.510260711
|
|
[3]
|
Jonas, M.M. (2002) Children with hepatitis C. Hepatology, 36, S173-S178. doi:10.1002/hep.1840360722
|
|
[4]
|
Davison, S.M. and Kelly, D.A. (2008) Management strategies for hepatitis C virus infection in children. Pediatric Drugs, 10, 357-365.
doi:10.2165/0148581-200810060-00003
|
|
[5]
|
Yeung, L.T., King, S.M. and Roberts, E.A. (2001) Mother-to-infant transmission of hepatitis C virus. Hepatology, 34, 223. doi:10.1053/jhep.2001.25885
|
|
[6]
|
Bortolotti, F., Resti, M., Giacchino, R., Crivellaro, C., Zancan, L., Azzari, C., et al. (1998) Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. Journal of Pediatrics, 133, 378-381.
doi:10.1016/S0022-3476(98)70273-2
|
|
[7]
|
Nelson, S.P. and Jonas, M.M. (1996) Hepatitis C infection in children who received extracorporeal membrane oxygenation. Journal of Pediatric Surgery, 31, 644.
doi:10.1016/S0022-3468(96)90665-X
|
|
[8]
|
Ni, Y.H., Chang, M.H., Lue, H.C., et al. (1994) Posttransfusion hepatitis C virus infection in children. Journal of Pediatrics, 124, 709.
doi:10.1016/S0022-3476(05)81359-9
|
|
[9]
|
Bortolotti, F., Verucchi, G., Cammà, C., Cabibbo, G., Zancan, L., Indolfi, G., et al. (2008) Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology, 13, 1900-1907.
doi:10.1053/j.gastro.2008.02.082
|
|
[10]
|
Hsu, S.C., Chang, M.H., Chen, D.S., Hsu, H.C. and Lee, C.Y. (1991) Non-A, non-B hepatitis in children: a clinical, histologic, and serologic study. Journal of Medical Virology, 35, 1-6. doi:10.1002/jmv.1890350102
|
|
[11]
|
Bortolotti, F., Vajro, P., Cadrobbi, P., Lepore, L., Zancan, L., Barbera, C., et al. (1992) Cryptogenic chronic liver disease and hepatitis C virus infection in children. Journal of Hepatology, 15, 73-76.
doi:10.1016/0168-8278(92)90014-G
|
|
[12]
|
Tovo, P.A., Pembrey, L.J. and Newell, M.L. (2000) Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. Journal of Infectious Diseases, 181, 419.
|
|
[13]
|
Gholson, C.F., Morgan, K., Catinis, G., Favrot, D., Taylor, B., Gonzalez, E. and Balart, L. (1997) Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. The American Journal of Gastroenterology, 92, 1788-1792.
|
|
[14]
|
Martinot-Peignoux, M., Boyer, N., Cazals-Hatem, D., Pham, B.N., Gervais, A., Le Breton, V., Levy, S., et al. (2001) Prospective study on anti-hepatitis C virus positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology, 34, 1000-1005.
doi:10.1053/jhep.2001.28458
|
|
[15]
|
Pradat, P., Alberti, A., Poynard, T., Esteban, J.I., Weiland, O., Marcellin, P., Badalamenti, S., et al. (2002) Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology, 36, 973-977.
|
|
[16]
|
Bortolotti, F., Jara, P., Diaz, C., Vajro, P., Hierro, L., Giacchino, R., et al. (1994) Post transfusion and community-acquired hepatitis C in childhood. Journal of Pediatric Gastroenterology and Nutrition, 18, 279-283.
doi:10.1097/00005176-199404000-00005
|
|
[17]
|
Casiraghi, M.A., De Paschale, M., Romanò, L., et al. (2004) Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology, 39, 90.
doi:10.1002/hep.20030
|
|
[18]
|
Bortolotti, F., Resti, M., Giacchino, R., Azzari, C., Gussetti, N., Crivellaro, C., et al. (1997) Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. Journal of Pediatrics, 130, 990-993. doi:10.1016/S0022-3476(97)70289-0
|
|
[19]
|
Kage, M., Fujisawa, T., Shiraki, K., Tanaka, T., Kimura, A., Shimamatsu, K., et al. (1997) Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology, 26, 771-775. doi:10.1002/hep.510260333
|
|
[20]
|
Badizadegan, K., Jonas, M.M., Ott, M.J., Nelson, S.P. and Perez-Atayde, A.R. (1998) Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology, 28, 1416-1423. doi:10.1002/hep.510280534
|
|
[21]
|
Guido, M., Rugge, M., Jara, P., Hierro, L., Giacchino, R., Larrauri, J., et al. (1998) Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology, 115, 1525-1529. doi:10.1016/S0016-5085(98)70032-0
|
|
[22]
|
European Paediatric Hepatitis C Virus Network. (2005) Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clinical Infectious Diseases, 41, 45. doi:10.1086/430601
|
|
[23]
|
Jonas, M.M., Baron, M.J., Bresee, J.S. and Schneider, L.C. (1996) Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics, 98, 211.
|
|
[24]
|
Kuroki, T., Nishiguchi, S., Fukuda, K., et al. (1993) Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis. Gut, 34, S52.
doi:10.1136/gut.34.2_Suppl.S52
|
|
[25]
|
Matsubara, T., Sumazaki, R. and Takita, H. (1995) Mother-to-infant transmission of hepatitis C virus: A prospective study. European Journal of Pediatrics, 154, 973. doi:10.1007/BF01958640
|
|
[26]
|
Sabatino, G., Ramenghi, L.A., di Marzio, M. and Pizzigallo, E. (1996) Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. European Journal of Epidemiology, 12, 443.
doi:10.1007/BF00143994
|
|
[27]
|
Mazza, C., Ravaggi, A., Rodella, A., et al. (1998) Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. Study Group for Vertical Transmission. Journal of Medical Virology, 54, 12.
doi:10.1002/(SICI)1096-9071(199801)54:1<12::AID-JMV3>3.0.CO;2-S
|
|
[28]
|
Giacchino, R., Tasso, L., Timitilli, A., et al. (1998) Vertical transmission of hepatitis C virus infection: usefulness of viremia detection in HIV-seronegative hepatitis C virus-seropositive mothers. Journal of Pediatrics, 132, 167. doi:10.1016/S0022-3476(98)70507-4
|
|
[29]
|
Manzini, P., Saracco, G., Cerchier, A., et al. (1995) Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission) persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology, 21, 328.
doi:10.1016/0270-9139(95)90088-8
|
|
[30]
|
Paccagnini, S., Principi, N., Massironi, E., et al. (1995) Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. The Pediatric Infectious Disease Journal, 14, 195.
doi:10.1097/00006454-199503000-00005
|
|
[31]
|
Sherman, M., Shafran, S., Burak, K., Doucette, K., Wong, W., Girgrah, N., et al. (2007) Management of chronic hepatitis C: Consensus guidelines. Canadian Journal of Gastroenterology, 21, 25C-34C.
|
|
[32]
|
Fazal, A.D. (2008) Current Standards in the Pharmacotherapy of Chronic Hepatitis C and Local Practices. Infectious Diseases Journal, 17, 93-7.
|
|
[33]
|
Conte, D., Fraquelli, M., Prati, D., et al. (2000) Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology, 31, 751.
doi:10.1002/hep.510310328
|
|
[34]
|
England, K., Pembrey, L., Tovo, P.A., Newell, M.L., European Paediatric HCV Network. (2005) Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatrica, 94, 444. doi:10.1111/j.1651-2227.2005.tb01916.x
|
|
[35]
|
American Academy of Pediatrics, Committee on Infectious Diseases (1997) 1997 Red book: Report of the committee on infectious diseases. 24th Edition, American Academy of Pediatrics, Elk Grove Village, 263.
|
|
[36]
|
Cagle, H.H., Jacob, J., Homan, C.E., et al. (2007) Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992. Archives of Pediatrics & Adolescent Medicine, 161, 125.
doi:10.1001/archpedi.161.2.125
|
|
[37]
|
Jonas, M.M. (2007) Finding adolescents and young adults with transfusion-associated hepatitis C: looking forward to looking back. Archives of Pediatrics & Adolescent Medicine, 161, 202. doi:10.1001/archpedi.161.2.202
|
|
[38]
|
Goodman, Z.D, Makhlouf, H.R., Liu, L., et al. (2008) Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial. Hepatology, 47, 836.
doi:10.1002/hep.22094
|
|
[39]
|
Bedossa, P. and Poynard T. (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, 289-293.
doi:10.1002/hep.510240201
|
|
[40]
|
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., et al. (1995) Histological grading and staging of chronic hepatitis. Journal of Hepatology, 22, 696-699. doi:10.1016/0168-8278(95)80226-6
|
|
[41]
|
Marcellin, P., Asselah, T. and Boyer, N. (2002) Fibrosis and disease progression in hepatitis C. Hepatology, 36, S47-S56. doi:10.1002/hep.1840360707
|
|
[42]
|
Strader, D.B., Wright, T., Thomas, D.L. and Seeff, L.B. (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology, 39, 1147-71. doi:10.1002/hep.20119
|
|
[43]
|
Gonzalez-Peralta, R., Haber, B.A., Jonas, M., Martin, S., Lang, T., Geffner, M., et al. (2002) Interferon-alfa 2b in combination with ribavirin for the treatment of chronic hepatitis C in children [Abstract]. Hepatology, 36, 311A.
|
|
[44]
|
González-Peralta, R.P., Kelly, D.A., Haber, B., Molleston, J., Murray, K.F., Jonas, M.M., et al. (2005) International Pediatric Hepatitis C Therapy Group. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics. Hepatology, 42, 1010-1018.
|
|
[45]
|
Jacobsen, I.M., Ahmed, F., Russo, M.W., Brown, R.S., Lebovics, E., Min, A., et al. (2003) Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: a trial in non-responders to interferon monotherapy or combination therapy and in combination therapy relapsers: final results. Gastroenterology, 124, A540.
|
|
[46]
|
Palumbo, E. (2009) Treatment for Chronic Hepatitis C in Children: A Review. American Journal of Therapeutics, 16, 446-450. doi:10.1097/MJT.0b013e31818a88c5
|
|
[47]
|
Ghany, M.G., Strader, D.B., Thomas, D.L. and Seeff, L.B., (2009) American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology, 49, 1335.
doi:10.1002/hep.22759
|
|
[48]
|
Wirth, S., Ribes-Koninckx, C., Calzado, M.A., et al. (2010) High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. Journal of Hepatology, 52, 501.
doi:10.1016/j.jhep.2010.01.016
|
|
[49]
|
Jara, P., Hierro, L., de la Vega, A., Díaz, C., Camarena, C., Frauca, E., et al. (2008) Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. The Pediatric Infectious Disease Journal, 27, 142-148.
|
|
[50]
|
Schwarz, K.B., Gonzalez-Peralta, R.P., Murray, K.F., et al. (2008) Peginterferon with or without ribavirin for chronic hepatitis C in children and adolescents: final results of the PEDS-C trial. Hepatology, 48, 418A.
|
|
[51]
|
Fazal, A.D., Salman, S.K., Fazal, R.S., Ahmed, E.R. and Saeeda, Y. (2009) Diagnosis and treatment of HCV infection in children: Suggested recommendations for the development of local guidelines. Journal of Pakistan Paediatric Association, 33, 203-210
|
|
[52]
|
Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2010) Managing HCV infection in paediatric age group: Suggested recommendations. Saudi Journal of Gastroenterology, 16, 230-235.
doi:10.4103/1319-3767.65182
|
|
[53]
|
Comanor, L., Minor, J., Conjeevaram, H.S., Roberts, E.A., Alvarez, F., Bern, E.M., et al. (2001) Impact of chronic hepatitis B and interferon-alpha therapy on growth of children. Journal of Viral Hepatitis, 8, 139-147.
doi:10.1046/j.1365-2893.2001.00262.x
|
|
[54]
|
Gottrand, F., Michaud, L., Guimber, D., Ategbo, S., Dubar, G., Turck, D., et al. (1996) Influence of recombinant interferon alpha on nutritional 1168 STRADER ET AL. HEPATOLOGY, April 2004 status and growth pattern in children with chronic viral hepatitis. European Journal of Pediatrics, 155, 1031-1034. doi:10.1007/BF02532525
|
|
[55]
|
(2009) Prescribing Information for PegIntron? package Insert. Drugs@FDA.gov
|
|
[56]
|
Delgado-Borrego, A., Healey, D., Negre, B., et al. (2010) Influence of body mass index on outcome of paediatric chronic hepatitis C virus infection. Journal of Pediatric Gastroenterology and Nutrition, 51, 191.
doi:10.1097/MPG.0b013e3181d32756
|
|
[57]
|
Bunn, S., Kelly, D., Murray, K.F., Shelton, M., Olson, A., Mieli-Vergani, G., et al. (2000) Safety, efficacy and pharmacokinetics of interferonalfa-2b and ribavirin in children with chronic hepatitis C [Abstract]. Hepatology, 32, 350A.
|
|
[58]
|
Maddrey, W.C. (1999) Safety of combination interferon alfa-2b/RBV therapy in chronic hepatitis C-relapsed and treatment-naive patients. Seminars in Liver Disease, 19, 67-75.
|
|
[59]
|
Mirza, R., Memon, I., Cheema, H.U., Ali, S., Thobani, S. and Shah, U. (2007) Recommendations for the treatment of chronic Hepatitis C infection in children. Journal Pakistan Medical Association, 57, 419-420
|
|
[60]
|
Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2008) Role of haematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients. Saudi Journal of Gastroenterology, 14, 151-157.
doi:10.4103/1319-3767.41739
|
|
[61]
|
Iacobellis, A., Siciliano, M., Perri, F., Annicchiarico, B.E., Leandro, G., Caruso, N., et al. (2007) Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study. Journal of Hepatology, 46, 206-212. doi:10.1016/j.jhep.2006.08.020
|
|
[62]
|
Tekin, F., Gunsar, F., Karasu, Z., Akarca, U. and Ersoz, G. (2008) Safety, tolerability, and efficacy of pegylated-interferon alfa-2a plus ribavirin in HCV-related decompensated cirrhotics. Alimentary Pharmacology & Therapeutics, 27, 1081-1085.
doi:10.1111/j.1365-2036.2008.03680.x
|
|
[63]
|
Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2010) Antiviral therapy in HCV-infected decompensated cirrhotics. Saudi Journal of Gastroenterology, 16, 310-314.
doi:10.4103/1319-3767.70632
|
|
[64]
|
Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2010) Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag. Saudi Journal of Gastroenterology, 16,
51-6. doi:10.4103/1319-3767.58772
|
|
[65]
|
Thomas, S.L., Newell, M.L., Peckham, C.S., et al. (1998) A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. International Journal of Epidemiology, 27, 108.
doi:10.1093/ije/27.1.108
|
|
[66]
|
Zanetti, A.R., Tanzi, E., Romanò, L., et al. (1998) A prospective study on mother-to-infant transmission of hepatitis C virus. Intervirology, 41, 208.
doi:10.1159/000024938
|
|
[67]
|
Terrault, N. (1998) Epidemiological evidence for perinatal transmission of hepatitis C virus. Viral Hepatitis Reviews, 4, 245.
|
|
[68]
|
Moriya, T., Sasaki, F., Mizui, M., et al. (1995) Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomedicine & Pharmacotherapy, 49, 59.
doi:10.1016/0753-3322(96)82587-X
|
|
[69]
|
Azzari, C., Resti, M., Moriondo, M., et al. (2000) Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood, 96, 2045.
|
|
[70]
|
Mast, E.E., Hwang, L.Y., Seto, D.S., et al. (2005) Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. Journal of Infectious Diseases, 192, 1880.
doi:10.1086/497701
|
|
[71]
|
Centers for Disease Control and Prevention (1998) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47, 1-39.
|
|
[72]
|
Mast, E.E. and Alter, M.J. (1997) Hepatitis C. Seminars in Pediatric Infectious Diseases, 8, 17-22.
doi:10.1016/S1045-1870(97)80005-2
|
|
[73]
|
McIntyre, P.G., Tosh, K. and McGuire, W. (2006) Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database of Systematic Reviews, 18, Article ID: CD005546.
|
|
[74]
|
ACOG Committee Opinion (1999) Breastfeeding and the risk of hepatitis C virus transmission. Number 220, August 1999. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. International Journal of Gynecology & Obstetrics, 66, 307.
|
|
[75]
|
Zanetti, A.R., Tanzi, E., Paccagnini, S., et al. (1995) Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet, 345, 289. doi:10.1016/S0140-6736(95)90277-5
|
|
[76]
|
Lin, H.H., Kao, J.H., Hsu, H.Y., et al. (1995) Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. Journal of Pediatrics, 126, 589.
doi:10.1016/S0022-3476(95)70356-X
|
|
[77]
|
Polywka, S., Schr?ter, M., Feucht, H.H., et al. (1999) Low risk of vertical transmission of hepatitis C virus by breast milk. Clinical Infectious Diseases, 29, 1327.
doi:10.1086/313473
|
|
[78]
|
Kumar, R.M. and Shahul, S. (1998) Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. Journal of Hepatology, 29, 191. doi:10.1016/S0168-8278(98)80003-2
|
|
[79]
|
American Academy of Pediatrics, Committee on Infectious Diseases (2009) Hepatitis C. In: Pickering, L.K., Ed., Red Book: 2009 Report of the Committee on Infectious Diseases, 28th Edition, American Academy of Pediatrics, Elk Grove Village, 357.
|
|
[80]
|
Fontaine, H., Nalpas, B., Carnot, F., et al. (2000) Effect of pregnancy on chronic hepatitis C: a case-control study. Lancet, 356, 1328. doi:10.1016/S0140-6736(00)02823-3
|
|
[81]
|
Di Martino, V., Lebray, P., Myers, R.P., et al. (2004) Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology, 40, 1426. doi:10.1002/hep.20463
|
|
[82]
|
Vegnente, A., Iorio, R., Saviano, A., et al. (1994) Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis c infection. The Pediatric Infectious Disease Journal, 13, 886-889.
|
|
[83]
|
Suzuki, T., Omata, K., Satoh, T., et al. (2005) Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients. Journal of Clinical Microbiology, 43, 4413-4417.
|
|
[84]
|
Buti, M., Valdes, A., Sanchez-Avila, F., Esteban, R. and Lurie, Y. (2003) Extending combination therapy with peginterferon-alpha-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases. Hepatology, 37, 1226-1227.
doi:10.1053/jhep.2003.50107
|
|
[85]
|
Berg, T., von Wegner, M., Nasser, S., et al. (2006) Extended treatment duration for hepatitis C virus type 1: Comparing 48 versus 72 of peginterferon-alpha-2a plus ribavirin. Gastroenterology, 130, 1086-1097.
doi:10.1053/j.gastro.2006.02.015
|
|
[86]
|
Ferencie, P., Lafen, H., Scherzer, T.M., et al. (2006) Customizing treatment with peginterferon-alpha-2A (40KD) (Pegasys[R]) plus ribavirin in patients with HCV genotype 1 or 4 infection. Hepatology, 44, 336A. (Abstract 390).
|